| Rosanna S Chapleau, PA-C | |
|
2 Elizabeth St, Bethel, CT 06801-2100 | |
| (203) 791-2221 | |
| (203) 791-0682 |
| Full Name | Rosanna S Chapleau |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 23 Years |
| Location | 2 Elizabeth St, Bethel, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073650180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 001118 (Connecticut) | Primary |
| 363A00000X | Physician Assistant | 001118 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prohealth Physicians Pc | 1355246950 | 236 |
News Archive
Current examples prove the feasibility of the 15 percent threshold newly defined by IQWiG for the acceptance of responder analyses in early benefit assessments of drugs.
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
The brains of Alzheimer's patients who have already developed clinical symptoms contain large clumps of the protein beta-amyloid, known as plaques. Many therapeutic approaches focus on removing plaques, but such attempts have met with only limited success to date.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosanna S Chapleau, PA-C 2 Elizabeth St, Bethel, CT 06801-2100 Ph: (203) 791-2221 | Rosanna S Chapleau, PA-C 2 Elizabeth St, Bethel, CT 06801-2100 Ph: (203) 791-2221 |
News Archive
Current examples prove the feasibility of the 15 percent threshold newly defined by IQWiG for the acceptance of responder analyses in early benefit assessments of drugs.
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
The brains of Alzheimer's patients who have already developed clinical symptoms contain large clumps of the protein beta-amyloid, known as plaques. Many therapeutic approaches focus on removing plaques, but such attempts have met with only limited success to date.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
› Verified 2 days ago
Ashley Nicole Courtney, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 24 Drummers Ln, Bethel, CT 06801 Phone: 865-693-0175 | |
Miss Ashley Nascimento, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6 Stony Hill Rd, Bethel, CT 06801 Phone: 203-456-8000 |